Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
27,736,858
-
Shares change
-
+2,022,191
-
Total reported value, excl. options
-
$305,936,220
-
Value change
-
+$24,728,608
-
Number of buys
-
40
-
Number of sells
-
-21
-
Price
-
$11.03
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q2 2017
81 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q2 2017.
AVADEL PHARMACEUTICALS - COM (AVDL) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,736,858 shares
.
Largest 10 shareholders include Broadfin Capital, LLC (4,133,464 shares), DEERFIELD MANAGEMENT CO (3,655,494 shares), JANUS HENDERSON GROUP PLC (2,184,911 shares), ACADIAN ASSET MANAGEMENT LLC (1,672,207 shares), MORGAN STANLEY (1,571,437 shares), DEUTSCHE BANK AG\ (1,540,546 shares), PERCEPTIVE ADVISORS LLC (1,429,114 shares), ARMISTICE CAPITAL, LLC (1,150,000 shares), BROWN CAPITAL MANAGEMENT LLC (871,467 shares), and FALCON POINT CAPITAL, LLC (855,101 shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.